Benign melanocytic naevi as a risk factor for malignant melanoma
- PMID: 3087514
- PMCID: PMC1340558
- DOI: 10.1136/bmj.292.6535.1555
Benign melanocytic naevi as a risk factor for malignant melanoma
Abstract
Examination of 180 patients with cutaneous malignant melanoma and 197 control patients in a case-control study showed that the risk of melanoma is strongly related to numbers of benign melanocytic naevi (moles). Some unusual features of naevi--a diameter exceeding 7 mm, colour variation, and irregular lateral outline--also showed a strong association with the risk of melanoma, but the relation of numbers of naevi to risk was present even in the group of patients whose naevi had none of these unusual features. Biopsy of clinically atypical naevi from several of the patients at highest risk generally did not show dysplastic histology. Thus a group of people at high risk of melanoma may be identified by using simple clinical assessment of naevi.
Similar articles
-
Melanocytic naevi and melanoma: an epidemiological perspective.Br J Dermatol. 1987 Aug;117(2):137-46. doi: 10.1111/j.1365-2133.1987.tb04109.x. Br J Dermatol. 1987. PMID: 3307891 Review.
-
Eruptive Cherry Angiomas and Skin Melanoma: Further Insights into an Intriguing Association.Dermatology. 2021;237(6):981-987. doi: 10.1159/000511101. Epub 2020 Nov 30. Dermatology. 2021. PMID: 33254169
-
Which moles matter? The association between melanocytic naevi and malignant melanomata.Br J Dermatol. 1981 Nov;105(5):607-9. doi: 10.1111/j.1365-2133.1981.tb00809.x. Br J Dermatol. 1981. PMID: 7295577 No abstract available.
-
Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma.Cancer. 1980 Oct 15;46(8):1787-94. doi: 10.1002/1097-0142(19801015)46:8<1787::aid-cncr2820460816>3.0.co;2-s. Cancer. 1980. PMID: 7427881
-
Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy.Br J Dermatol. 2005 Jan;152(1):87-92. doi: 10.1111/j.1365-2133.2005.06370.x. Br J Dermatol. 2005. PMID: 15656806 Review.
Cited by
-
Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic Variants.Front Oncol. 2022 Mar 16;12:837057. doi: 10.3389/fonc.2022.837057. eCollection 2022. Front Oncol. 2022. PMID: 35372037 Free PMC article. Review.
-
Professor Rona MacKie, Scottish dermatologist and melanoma authority.Int J Womens Dermatol. 2015 Oct 1;1(4):187-190. doi: 10.1016/j.ijwd.2015.08.003. eCollection 2015 Dec. Int J Womens Dermatol. 2015. PMID: 28491989 Free PMC article. No abstract available.
-
Use of host factors to identify people at high risk for cutaneous malignant melanoma.CMAJ. 1992 Aug 15;147(4):445-53. CMAJ. 1992. PMID: 1498755 Free PMC article.
-
Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls.Int J Epidemiol. 2009 Jun;38(3):814-30. doi: 10.1093/ije/dyp166. Epub 2009 Apr 8. Int J Epidemiol. 2009. PMID: 19359257 Free PMC article.
-
Development and validation of a melanoma risk score based on pooled data from 16 case-control studies.Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):817-24. doi: 10.1158/1055-9965.EPI-14-1062. Epub 2015 Feb 24. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 25713022 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical